Borgeson Blake

Director

1 company

Strong

Trades Analyzed

12M Win Rate

69.6%

Avg 3M Return

+3.4%

Avg 12M Return

+12.4%

Borgeson Blake is a Director at RECURSION PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $21.1M based on current market prices.

Holdings by Company

RXRXJan 6, 2026

Current Shares6.65M

Value$21.15M

Net Activity-1,101,585

Bought: 0Sold: 1.10M

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 23, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	11,447	$8.48	$97,040.80	-0.2%	-21.2%	-25.1%
Jul 9, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	11,447	$7.32	$83,734.81	-0.2%	-16.9%	-24.9%
Jun 25, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	11,447	$9.51	$108,806.02	-0.2%	-28.9%	-45.0%
Jun 11, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	11,447	$8.45	$96,762.64	-0.2%	-28.7%	-37.1%
May 28, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	11,447	$9.17	$104,942.66	-0.2%	-12.2%	-51.1%
May 14, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	20,054	$10.12	$202,934.45	-0.3%	-40.0%	-57.1%
Apr 30, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	11,447	$7.95	$90,963.59	-0.2%	+4.7%	-28.5%
Apr 16, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	11,447	$7.66	$87,725.23	-0.2%	+8.3%	-29.7%
Apr 2, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	11,447	$8.82	$100,941.94	-0.2%	-14.9%	-39.7%
Mar 19, 2024	RXRX Recursion Pharmaceuticals, Inc.	Director	Sell	20,054	$10.79	$216,422.77	-0.3%	-12.8%	-38.8%